Fundraising FoxBuilders VC — 2021 Investments
5 investments dated 2021 · listed companies and verified rows first · show all
Andes is a mission-driven company focused on protecting the planet and applying technology in a nature-related context.
AgTechBiotechClimate Tech
Co-investorsAccelr8Capria VenturesCavallo VenturesGermin8 VenturesKdT VenturesSunna Ventures+3 more
Cavallo Ventures is the venture capital arm of Wilbur-Ellis, investing in innovative technology companies across agriculture, specialty chemicals, and animal nutrition sectors.
AgTechEnterprise Software
Michael Wilbur(President)in
Co-investorsWilbur-Ellis [Cavallo]Accelr8Germin8 VenturesKdT VenturesLeaps by Bayer
Enveda operates a drug-discovery platform that analyzes natural samples—primarily plant-derived molecules—using mass spectrometry, AI foundation models, and automated high-throughput labs to identify their chemical structures and therapeutic properties.
AI & Machine LearningBiotechDeep TechBoulder, US
Viswa Colluru(Founder)inDaniel Wee(Executive Officer)Pieter Dorrestein(Founder)Viswa Colluru Pieter Dorrestein(Founder)
BoardRohit Sharma(Director)Zavain Dar(Director)in
Co-investorsAmino CollectiveBoulder VenturesCatalio Capital Management, LPCox EnterprisesFPVGaingels+21 more
__Twitter.png)
FitBiomics develops proprietary probiotic microbes derived from research on the microbiomes of elite athletes and healthy people, offering products such as Nella and V•Nella that are tested for quality, safety, and efficacy.
BiotechConsumerWellness & FitnessNew York, US
Jonathan Scheiman(Executive Officer, Director, Promoter)in
Co-investorsIcebook Investments Corp.
Wingback provides a platform for B2B SaaS companies to manage monetization, pricing, packaging, and invoicing.
Data & InfrastructureEnterprise SoftwareFintechSaaSSan Francisco, US
Torben Friehe(Founder)inYANN LERETAILLE(Director)inYann Leretaillein
Co-investors42CAPY CombinatorKarma VenturesOn DeckUnpopular Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.